08:33 AM EDT, 09/15/2026 (MT Newswires) -- Beximco Pharmaceuticals (BXP.L) on Tuesday confirmed media reports that it is considering changes to its board composition, including the potential resignation of Salman Rahman as vice chairman. The London-listed pharmaceutical company said the reports, which appeared in Bangladeshi media on the same day, relate to proposals being discussed with the Bangladesh Securities and Exchange Commission as part of efforts to settle two legal cases over the regulator's appointment of nine additional independent nonexecutive directors to the company's board. The cases are pending before the High Court Division of the Supreme Court of Bangladesh.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.